Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Regulatory

FDA moves toward easing restrictions on certain peptides

 April 16, 2026

BioPharma Dive

The agency s decision to hold an advisory committee meeting on the topic comes after HHS Secretary Robert F.

RegulatoryRead full story

Post navigation

Lilly’s new obesity pill passes heart safety test in diabetes →
← Erica Schwartz, ex-deputy surgeon general, picked to be next CDC director

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com